viewRedx Pharma PLC

Redx Pharma plc - Second Price Monitoring Extn

RNS Number : 8926R
Redx Pharma plc
02 July 2020

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Quick facts: Redx Pharma PLC

Price: 67.5

Market: AIM
Market Cap: £131.79 m

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


RedX Pharma presents at the Proactive One2One Virtual Conference

Redx Pharma's (LON:REDX) Lisa Anson pitches to investors at the One2One Proactive virtual forum. The company is focused on the development of novel targeted medicines to validated anti-cancer and fibrosis targets in areas of unmet need. Redx Pharma uses its proven drug discovery expertise...

1 day, 12 hours ago

2 min read